A Multicenter, single blind, dose-escalation, Investigator initiated trial for single intravenous administration of NK-104-NP to male adult Healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 26 Feb 2015
Price : $35 *
At a glance
- Drugs Pitavastatin (Primary)
- Indications Dyslipidaemias; Hypercholesterolaemia; Hyperlipidaemia
- Focus Adverse reactions
- 25 Feb 2015 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 04 Dec 2014 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 27 Aug 2014 New trial record